ClinicalTrials.gg
RecruitingNCT06916052COLObsUpdated Jun 15, 2025

Study to Analyse the Use of a Digital Platform for the Preparation and Follow-up of Patients With Scheduled Outpatients Colonoscopy

An observational study in Outpatient Colonoscopy, sponsored by Persei Vivarium. Recruiting at 1 site in Spain. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2025-06-15.

Sponsored by Persei Vivarium · Observational

How we know

From the registry’s dates

  • Primary completion was expected by Jul 2025, 1 year 4 months ago, but the record still lists the study as recruiting.
  • Started Mar 2025; still recruiting 1 year 8 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
225
Ages
18 Years to 80 Years
Sex
All
01

Study summary

The goal of this clinical trial investigation with device is to to analyze the use of the Caaring® digital platform for the preparation and follow-up of scheduled colonoscopy.

Colonoscopy is a difficult procedure, and it is estimated that bowel preparation is inadequate in about 25% of patients. The main question it aims to answer is if the use of a digital platform (Caaring®) could be an effective tool for reducing the percentage of inadequate bowel preparations in patients with a scheduled colonoscopy. To this end, the application will provide precise instructions to patients.

A prospective, single-center, observational study with software device: The recruitment phase is expected to last two months. Patients will be followed for one month after the colonoscopy and 14 days prior to it.

Additionally, measuring patient experience and monitoring adverse effects after a colonoscopy are crucial to improving the safety of colonoscopies and the quality of healthcare, promoting higher quality colonoscopy services.

For that to happen, participants must have sufficient technological skills to use a smartphone.

Read the detailed description

A prospective, single-center, observational study with software device. The protocol and informed consent documents have been reviewed and approved by the hospital human subjects reviewboard and the study will be performed in accordance with the Declaration of Helsinki.

02

Conditions studied

  • Outpatient Colonoscopy

Keywords

  • Colonoscopy preparation
  • Digital Platform
  • Caaring
  • Outpatient colonoscopy
  • DTx
  • Patient-reported Data
  • Real World Data
  • RWD
  • PROMs
  • Digital Health
03

In context

Lead sponsor

Persei Vivarium is the lead sponsor of 7 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

All patients from the Hospital Clínic in Barcelona diagnosed with a scheduled colonoscopy who meet the selection criteria and sign the informed consent will be included.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18 or older.
  • Signed .
  • Patients scheduled for outpatient colonoscopy.
  • Patients able to complete the study questionnaires.
  • Patients who regularly use a smartphone

Exclusion criteria

Exclusion Criteria:

  • Patients enrolled in the population-based colorectal cancer screening program with a positive fecal occult blood test.
  • Minors or elderly patients (over 80 years of age).
  • Patients with prior colorectal surgery.
  • Patients who, in the opinion of the researcher, will not be able to commit to follow-up or lack adequate technological skills.
  • Inability to provide adequate .
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
225 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Percentage of patients scheduled colonoscopy who have an adequate bowel preparation.

    Percentage of colonoscopies with adequate bowel preparation defined as having a total Boston Bowel Preparation Scale (BBPS) score greater than or equal of 6 and BBPS score for per colon segment ≥2.

    Time frame: Day 0, (Colonoscopy Day)

Secondary outcomes

  1. Active Patient Rate

    Active patient rate defined as the number of patients who activate their account divided by the total number of patients guests.

    Time frame: Day -14 (14 days before the colonoscopy)

  2. Patients with section completed: Treatments

    Of active patients, percentage who completes the section Treatments

    Time frame: Day -14 (14 days before the colonoscopy)

  3. Patients with section completed: Pick up the bowel preparation

    Of active patients, percentage who completes the section Pick up the bowel preparation.

    Time frame: Day -10 (10 days before colonoscopy)

  4. Patients with section completed: Colonoscopy Preparation Solution (laxative).

    Of active patients, percentage who completes the secion Colonoscopy Preparation Solution (laxative).

    Time frame: Day 2 (2 days after colonoscopy)

  5. Patients with section completed: Procedure satisfaction questionnaire

    Of active patients, percentage who completed the section Procedure satisfaction questionnaire.

    Time frame: Day 3 (3 days after colonoscopy)

  6. Patients with section completed: Adverse Events

    Of active patients, percentage of patients who completes the Adverse Events section.

    Time frame: Day 1, Day 14 and Day 30

  7. Percentage of patients with 100% of data completed

    Percentage of patients with 100% of data completed in the application.

    Time frame: Day 31 (31days after the colonoscopy)

  8. Patients who view educational materials: Pick up the laxative

    Of active patients, percentage of Patients who view the educational materials: Pick up the laxative. The app will reflect the date and time that patients viewed that information.

    Time frame: Day -10 (10 days before colonoscopy)

  9. Patients who view educational materials: Diet

    Of active patients, percentage of Patients who view the educational material: Diet. The app will reflect the date and time that patients viewed that information.

    Time frame: Day -4 (4 days before colonoscopy)

  10. Patients who view educational materials: Adequate preparation for a colonoscopy

    Of active patients, percentage of Patients who view the educational material: Adequate preparation for a colonoscopy . The app will reflect the date and time that patients viewed that information.

    Time frame: Day -4 (4 days before colonoscopy)

  11. Patients who view educational materials: Bring someone

    Of active patients, percentage of Patients who view the educational material: bring someone. The app will reflect the date and time that patients viewed that information.

    Time frame: Day -4 (4 days before colonoscopy)

  12. Patients who view educational materials: Instructions for your colonoscopy

    Of active patients, percentage of Patients who view the educational material: Instructions for your colonoscopy. The app will reflect the date and time that patients viewed that information.

    Time frame: Day -3 (3 days before colonoscopy)

  13. Percentage of patients with 100% of education materials viewed.

    Percentage of patients with 100% of educational materials viewed in the application.

    Time frame: Day 31 (31days after the colonoscopy)

  14. Percentage of patients who take the laxative

    Percentage of patients who take the laxative.

    Time frame: Day -3 (3 days before the colonoscopy)

  15. Patient satisfaction with the bowel preparation (laxative)

    The patient satisfaction with the bowel preparation will be measured through a specific satisfaction questionnaire created for this purpose. (Value 1-4). A higher score reflects greater satisfaction with software care.

    Time frame: Day 2 (2 days after colonoscopy)

  16. Patient satisfaction with the colonoscopy experience

    The patient satisfaction with the colonoscopy experience will be measured through a specific satisfaction questionnaire created for this purpose. (Value 1-5). A higher score reflects greater satisfaction with software care.

    Time frame: Day 3 (3 days after colonoscopy)

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Mar 2025 (actual). Primary completion is estimated for Jul 2025, 4 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 31, 2025
First posted
Apr 8, 2025
StartActual
Mar 13, 2025
Primary completionEst.
Jul 2025
CompletionEst.
Aug 2025
Last update
Jun 15, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 15, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06916052
Lead sponsor
Persei Vivarium
Collaborators
Effice Servicios Para la Investigacion S.L.
Responsible party
Sponsor
First posted
Apr 8, 2025
Start date
Mar 13, 2025
Primary completion
Jul 2025 (estimated)
Completion
Aug 2025 (estimated)
Last update
Jun 15, 2025

Study contacts

Roberto Bravo
Contact
roberto.bravo@perseivivarium.com
+34 915004013

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion